Healthcare / Medical Care FacilitiesHKSE
$7.40
-0.20 (-2.63%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 19%
FCF escenarios
weak_data · normalized FCF $57.7M · quality 51.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
37/100
D
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$2.9B
P/E
740.0x
↑EV/EBITDA
13.1x
↑ROE
0.2%
↓Gross Margin
33.8%
↓Debt/Equity
0.31
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+3.6%
FCF CAGR
—
FCF margin
6.6%
FCF / Net income
15.41x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $873.1M · net income $3.7M · FCF $57.7M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $873.1M | $873.1M | $760.6M | $928.9M | $784.4M |
| Net Income | $3.7M | $3.7M | $-45.9M | $44.4M | $364000.00 |
| EBITDA | $223.5M | $223.5M | $169.3M | $256.2M | $207.9M |
| EPS | — | — | -0.13 | 0.12 | 0.00 |
| Gross Margin | 33.8% | 33.8% | 36.5% | 35.8% | 30.2% |
| Operating Margin | 5.7% | 5.7% | -1.9% | 8.6% | 5.5% |
| Net Margin | 0.4% | 0.4% | -6.0% | 4.8% | 0.0% |
| Balance Sheet | |||||
| Debt/Equity | 0.31 | 0.31 | 0.40 | 0.30 | 0.38 |
| Current Ratio | 2.79 | 2.79 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $57.7M | $57.7M | $-298.8M | $104.9M | $-73.5M |
| Returns | |||||
| ROE | 0.2% | 0.2% | -3.2% | 3.4% | 0.0% |
| Valuation | |||||
| P/E | 740.00 | 740.00 | — | — | — |
| EV/EBITDA | 13.09 | 13.09 | 133.05 | — | — |
| P/B | 1.47 | 1.47 | 15.26 | — | — |
| Growth & Yield | |||||
| Revenue Growth | 14.8% | 14.8% | -18.1% | 18.4% | — |
| EPS Growth | — | — | -205.9% | 12096.9% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-61.5%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.13 → n/d
Residual
-61.5%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.